P.2.b.048 Functional impairment in major depressive disorder: preliminary findings of the PERFORM study von Saragoussi, D, Haro, J.M, Boulenger, J.P, Lamy, F.X, Di Nicola, S, Rive, B

Volltext

The Burden of Treatment Change in Major Depressive Disorder: Comparison of Switch Versus Non-Switch Patients in the Perform Study von Boulenger, J.P, Haro, J.M, Lamy, F.X, Brignone, M, Caillou, H, Rive, B, Saragoussi, D

Volltext

P.2.c.024 A double-blind, randomised, placebocontrolled, relapse-prevention study with Lu AA21004 in patients with major depressive disorder von Dragheim, M, Loft, H, Florea, I, Boulenger, J.P

Volltext

Patient-Reported Cognitive Dysfunction Negatively Impacts Functioning in Patients with Major Depressive Disorder – Preliminary Findings from the Perform Study von Saragoussi, D, Haro, J.M, Boulenger, J.P, Jönsson, B, Knapp, M, Caillou, H, Chalem, Y, Milea, D, François, C

Volltext

P.2.a.009 Pooled analysis: 2 randomised clinical trials confirms superiority of escitalopram over paroxetine in treatment of major depressive disorder von Kasper, S, Baldwin, D, Boulenger, J.P

Volltext

Childhood Trauma increases suicidal behaviour in a treatment-resistant depression population: a FACE-DR report von Yrondi, Antoine, Vaiva, Guillaume, Walter, Michel, D Amato, Thierry, Bellivier, Frank, Bennabi, Djamila, Bougerol, Thierry, Camus, Vincent, Doumy, Olivier, Genty, Jean-Baptiste, Haffen, Emmanuel, Holtzmann, Jérôme, Horn, Mathilde, Lançon, Christophe, Leboyer, Marion, Llorca, Pierre-Michel, Maruani, Julia, Moirand, Rémi, Molière, Fanny, Petrucci, Jean, Richieri, Raphaelle, Samalin, Ludovic, Schmitt, Laurent, Stephan, Florian, Courtet, Philippe, El-Hage, Wissam, Aouizerate, Bruno, Aouizerate, B., Bennabi, D., Leboyer, M., Haffen, E., Llorca, P.M., Barteau, V., Bensalem, S., Laouamri, H., Souryis, Karmene, Mallet, L., Yon, L., Petrucci, J., Genty, J.B., Yrondi, A., Pierre, D., Schmitt, L., Sarrail, M., Haffen, E., Bennabi, Djamila, Ryff, I., Beuchet, E., Tio, G., Cappe, C., Clerc, E., Llorca, P.M., Garnier, M., Honciuc, R.M., Allauze, E., Blanc, O., Bellivier, F., Allaili, N., Nieto, I., Meheust, J., Sunthavy, Y., Maruani, J., Bougerol, T., Polosan, M., Courvoisier, P., Holtzmann, J., Fredembach, B., Foubert-Andreani, S., Camus, V., El Hage, W., D’Amato, T., Haesebaert, F., Dubien, C., Lefebvre, M., Meznad, A., Brunelin, J., Moirand, R., Aouizerate, B., Doumy, O., Lancon, C., Richieri, R., Peri, P., Faugere, M., Faget-Agius, C., Courtet, P., Boulenger, J.P., Moliere, F., Stephan, F., Walter, M., Mesmeur, C., Vaiva, G., Horn, M.

Volltext

P.2.h.002 Paroxetine effects on emotions: a 4-week randomized placebo-controlled pilot study in psychologists and psychiatrists von Cass´e-Perrot, C, Nguyen, N, Jouve, E, Souville, M, Boulenger, J.P, Fallissard, B, Lan¸con, C, Rouillon, F, Besnier, N, Blin, O

Volltext

PMH13 - The Burden of Treatment Change in Major Depressive Disorder: Comparison of Switch Versus Non-Switch Patients in the Perform Study von Boulenger, J.P., Haro, J.M., Lamy, F.X., Brignone, M., Caillou, H., Rive, B., Saragoussi, D.

Volltext

P226 Effets d’un réentraînement en endurance au LIPOX max chez des patients traités par psychotropes von Romain, A.J, Fedou, C, Brun, J.F, Raimondi, R, Attal, J, Hermes, A, Mercier, J, Boulenger, J.P

Volltext

PMH14 - Patient-Reported Cognitive Dysfunction Negatively Impacts Functioning in Patients with Major Depressive Disorder – Preliminary Findings from the Perform Study von Saragoussi, D., Haro, J.M., Boulenger, J.P., Jönsson, B., Knapp, M., Caillou, H., Chalem, Y., Milea, D., François, C.

Volltext

Appropriate medication prescribing in older people von Blain, H, Rambourg, P, Le Quellec, A, Ayach, L, Biboulet, P, Bismuth, M, Blain, A, Boulenger, J-P, Celton, B, Combe, B, Dauvilliers, Y, Davy, J-M, Geny, C, Hemmi, P, Hillaire-Buys, D, Jalabert, A, Jung, B, Leclercq, F, Léglise, M-S, Morel, J, Mourad, G, Ponrouch, M-P, Puisieux, F, Quantin, X, Quéré, I, Renard, E, Ribstein, J, Roch-Torreilles, I, Rolland, Y, Rosant, D, Terminet, A, Thuret, R, Villiet, M, Deshormières, N, Bourret, R, Bousquet, J, Jonquet, O, Millat, B

Volltext

D’une indication à l’autre : intérêt des études long terme von Boulenger, J.P.

Volltext

Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients von MARTINOT, J.-L, PERON-MAGNAN, P, SYROTA, A, HURET, J.-D, MAZOYER, B, BARON, J.-C, BOULENGER, J.-P, LOC'H, C, MAZIERE, B, CAILLARD, V, LOO, H

Volltext

Plasma and platelet catecholamine concentrations as predictors of the cardiovascular, psychological and panic-like-symptoms induced by CCK-4 in healthy subjects von Jerabek, I., Boulenger, J.P., Lavallée, Y.J., Jolicoeur, F.B.

Volltext

Plasma neuropeptide Y reactivity to cholecystokinin challenge in panic disorders and normal controls von Boulenger, J.P., Jerabek, I., Bradwijn, J., Lavallée, Y.J., Cadieux, A.

Volltext

Do anxious patients referred to psychiatrists differ from those recruited through newspaper advertising? von Boulenger, J.P, McCusker, J., Ouellet, N., Miller, J.M., Bellavance, F.

Volltext

Caffeine ingestion compared with lactate infusion as a model of panic von Uhde, Tom, Boulenger, J.P.

Volltext

Effects of chronic caffeine on brain adenosine receptors: Regional and ontogenetic studies von Marangos, Paul J., Boulenger, Jean-Philippe, Patel, Jitendra

Volltext

Human plasma NPY-like immunoreactivity in patients with depressive and panic disorder von Hermès, A., Boulenger, J.P., Cadieux, A., Jerabek, I., Caci, H., Lavallée, Y.J., Darcourt, G.

Volltext

Brain concentrations of amines and neuropeptide Y-LI following peripheral administration of cholecystokinin-4 von Gilbert, A.-K., Jerabek, I., Bolongo, M., Boulenger, J.P., Cadieux, A., Jolicoeur, F.B.

Volltext